Related Experiment Videos
Basophil and eosinophil activation by CC chemokines
1Institute of Immunology and Allergology Inselspital, University of Bern, Switzerland.
International Archives of Allergy and Immunology
|May 1, 1995
Summary
CC chemokines selectively target immune cells like monocytes and lymphocytes, but not neutrophils. Understanding these chemokine receptors and their distinct functions could lead to targeted anti-inflammatory drugs for chronic inflammation and allergic diseases.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- CC chemokines are crucial for immune cell trafficking and activation.
- Selective attraction of monocytes, lymphocytes, eosinophils, and basophils by CC chemokines is observed, but not neutrophils.
- Distinct target cell selectivities suggest roles in chronic inflammation and allergic diseases.
Purpose of the Study:
- To investigate the distinct bioactivities and target cell profiles of human CC chemokines.
- To identify and characterize CC chemokine receptors on basophils and eosinophils.
- To explore structure-function relationships of CC chemokines for developing targeted therapies.
Main Methods:
- Functional and desensitization studies on basophils and eosinophils.
- Analysis of bioactivities and target cell profiles for all six human CC chemokines.
- Utilizing chemokine mutants and hybrids to study structure-function relationships.
Main Results:
- At least three distinct G-protein-coupled CC chemokine receptors identified on basophils, and two on eosinophils.
- These receptors exhibit partially selective and overlapping ligand specificities, mediating distinct functions.
- CC chemokine sequence homology does not predict cell function or preferential activation; discrete sequence motifs are likely key.
Conclusions:
- CC chemokines possess distinct bioactivities and target cell profiles, mediated by specific CC chemokine receptors.
- Structure-function analyses reveal the importance of discrete sequence motifs in chemokine-receptor interactions.
- These findings pave the way for developing disease-selective anti-inflammatory antagonists.